Results 211 to 220 of about 1,143,531 (409)
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
International Forum of Allergy and Rhinology, 2018 S. Wise, Sandra Y. Lin, E. Toskala, R. Orlandi, C. Akdis, J. Alt, A. Azar, F. Baroody, C. Bachert, G. Canonica, T. Chacko, C. Cingi, G. Ciprandi, J. Corey, L. Cox, P. Creticos, A. Custovic, C. Damask, A. Deconde, J. DelGaudio, Charles S. Ebert, J. Eloy, C. Flanagan, W. Fokkens, C. Franzese, J. Gosepath, A. Halderman, R. Hamilton, H. Hoffman, J. Hohlfeld, S. Houser, P. Hwang, C. Incorvaia, D. Jarvis, Ayesha N. Khalid, M. Kilpeläinen, T. Kingdom, H. Krouse, D. Larenas-Linnemann, A. Laury, Stella E. Lee, J. Levy, A. Luong, B. Marple, E. McCoul, K. McMains, E. Mélen, J. Mims, G. Moscato, J. Mullol, H. Nelson, M. Patadia, R. Pawankar, O. Pfaar, M. Platt, W. Reisacher, C. Rondón, L. Rudmik, M. Ryan, J. Sastre, R. Schlosser, R. Settipane, H. Sharma, A. Sheikh, Timothy L. Smith, P. Tantilipikorn, J. Tversky, Maria C. Veling, D. Wang, M. Westman, M. Wickman, M. Zacharek +71 moresemanticscholar +1 more sourceSarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and One‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study
Arthritis Care &Research, Accepted Article.Objective
This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods
This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<Fabrizio De Benedetti, Inmaculada C. Penadés, Irina Nikishina, Ivan Foeldvari, Alberto J. Spindler, Anna Kozlova, Nadina Rubio‐Pérez, Pierre Quartier, Zbigniew Żuber, Raul Barria, Daniel Clemente, Gabriel V. Cornejo, Katherine Marzan, Nancy Liu, Christine Xu, Stephen DiMartino, Angeliki Giannelou, Fei Cao‐Ghoul, Bolanle Akinlade, Lydie Baret‐Cormel +19 morewiley +1 more sourceEAACI Guidelines on allergen immunotherapy: IgE‐mediated food allergy
Allergy. European Journal of Allergy and Clinical Immunology, 2018 G. Pajno, M. Fernández-Rivas, S. Arasi, Graham Roberts, C. Akdis, M. Álvaro-Lozano, K. Beyer, C. Bindslev‐Jensen, W. Burks, M. Ebisawa, P. Eigenmann, E. Knol, Kari C. Nadeau, Lars K Poulsen, R. Ree, Alexandra F. Santos, G. Toit, S. Dhami, U. Nurmatov, Y. Boloh, M. Makela, L. O’Mahony, N. Papadopoulos, C. Saçkesen, I. Agache, E. Angier, S. Halken, M. Jutel, Susanne Lau, O. Pfaar, D. Ryan, G. Sturm, E. Varga, R. Gerth Wijk, A. Sheikh, A. Muraro, G. Pajno, CA Akdis, Beyer K Bindslev-Jensen, KC Nadeau, LK Poulsen, R. Vanree, AF Santos, Dhami Toit G, Sturm Ryan D, E. Varga, Gerth R. van Wijk +46 moresemanticscholar +1 more sourceA Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development
Arthritis Care &Research, EarlyView.Objective
A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)Shivani Garg, Izzy Hartel, Lisa R. Sammaritano, Anca Askanase, Bonnie L. Bermas, Maria Dall'Era, Alí Duarte‐García, Victoria P. Werth, Brad Rovin, Reem A. Mustafa, Amy S. Turner, Bené Williams, Brian L. Ung, Hiya Bhavsar, Monique C. Gore‐Massy, Nahirannette Pulido, Natacha Guerrero, Natalie M. Smith, Wambui Machua, Linda T. Hiraki, Mary Beth Son +20 morewiley +1 more sourceEAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy
Allergy. European Journal of Allergy and Clinical Immunology, 2018 G. Sturm, E. Varga, G. Roberts, H. Mosbech, M. Biló, C. Akdis, D. Antolín-Amérigo, E. Cichocka-Jarosz, R. Gawlik, T. Jakob, M. Košnik, J. Lange, E. Mingomataj, D. Mitsias, M. Ollert, J. O. Elberink, O. Pfaar, C. Pitsios, V. Pravettoni, F. Ruëff, B. Sin, I. Agache, Elizabeth, Angier, S. Arasi, M. Calderón, M. Fernández-Rivas, Susanne, Halken, M. Jutel, S. Lau, G. Pajno, R. Ree, Dermot, Ryan, O. Spranger, R. V. Wijk, S. Dhami, H. Zaman, Aziz, Sheikh, A. Muraro +41 moresemanticscholar +1 more sourceBeyond Inflammation: Why Understanding the Brain Matters in Inflammatory Arthritis
Arthritis Care &Research, EarlyView.Persistent pain remains a major challenge in inflammatory arthritis, even when joint inflammation is well controlled. Pain and associated symptoms such as fatigue cannot be explained by peripheral inflammation alone but reflect altered central pain processing. These changes may arise through “top‐down” mechanisms, reflecting pre‐existing dysfunction in Eoin M. Kelleher, Rosario Meouchi, Anushka Irani +2 morewiley +1 more sourceResponse to allopurinol and febuxostat according to the fractional excretion of urate in men with gout
Arthritis Care &Research, Accepted Article.Background
Body mass index (BMI), glomerular filtration rate (GFR), and pretreatment urate levels have been reported to influence the urate‐lowering response to allopurinol. We investigated whether the fractional excretion of urate (FEUA) also modulates this response and relates to oxypurinol concentrations. We further evaluated its potential influence Pascal Richette, Anouk Walter‐Petrich, Quang Dinh Nguyen, Matthieu Resche‐Rigon, Quang Huy Dinh Nguyen, Minh Duc Do, Thao Phuong Mai, Tuan Duc Nguyen, Fernando Perez‐Ruiz, Emmanuel Letavernier, Tristan Pascart, Augustin Latourte, Hang Korng Ea, Thomas Bardin +13 morewiley +1 more source